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Abstract
Purpose To evaluate accuracy of MRI in detecting renal tumor pseudocapsule (PC) invasion and to propose a classification 
based on imaging of PC status in patients with renal cell carcinoma.
Methods From January 2017 to June 2018, 58 consecutive patients with localized renal cell carcinoma were prospec-
tively enrolled. MRI was performed preoperatively and PC was classified, according to its features, as follows: MRI-Cap 0 
(absence of PC), MRI-Cap 1 (presence of a clearly identifiable PC), MRI-Cap 2 (focally interrupted PC), and MRI-Cap 3 
(clearly interrupted and infiltrated PC). A 3D image reconstruction showing MRI-Cap score was provided to both surgeon 
and pathologist to obtain complete preoperative evaluation and to compare imaging and pathology reports. All patients 
underwent laparoscopic partial nephrectomy. In surgical specimens, PC was classified according to the renal tumor capsule 
invasion scoring system (i-Cap).
Results A concordance between MRI-Cap and i-Cap was found in 50/58 (86%) cases. ρ coefficient for each MRI-cap and 
iCap categories was: MRI-Cap 0: 0.89 (p < 0.0001), MRI-Cap1: 0.75 (p < 0.0001), MRI-Cap 2: 0.76 (p < 0.0001), and 
MRI-Cap3: 0.87 (p < 0.0001). Sensitivity, specificity, positive predictive value, negative predictive value, and AUC were: 
MRI-Cap 0: Se 97.87% Spec 83.3%, PPV 95.8%, NPV 90.9%, and AUC 90.9; MRI-Cap 1: Se 77% Spec 95.5%, PPV 83.3%, 
NPV 93.5%, and AUC 0.86; MRI-Cap 2- iCap 2: Se 88% Spec 90%, PPV 79%, NPV 95%, and AUC 0.89; MRI-Cap 3: Se 
94% Spec 95%, PPV 88%, NPV 97%, and AUC 0.94.
Conclusions MRI-Cap classification is accurate in evaluating renal tumor PC features. PC features can provide an imaging-
guided landmark to figure out where a minimal margin could be preferable during nephron-sparing surgery
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Introduction
Partial nephrectomy (PN) can be performed, either with an 
open, pure laparoscopic- or robot-assisted approach, based 
on surgeon’s expertise and skills [1]. In patients who elect 
PN, physicians should prioritize preservation of renal func-
tion through efforts to optimize nephron mass preservation 
and avoidance of prolonged warm ischemia [2]. Among NSS 
techniques, tumor enucleation (TE) maximally preserves 
normal renal parenchyma and is enabled by the presence of 
tumor PC. This is a fibrous band of compressed renal paren-
chyma that separates the tumor from the adjacent healthy 
renal parenchyma, thus, providing a natural cleavage plane 
during surgery [3]. The amount of healthy renal parenchyma 
preserved during PN represents one important modifiable 
factor impacting on renal function [4]. The debate on pros 
and cons of TE for localized renal masses is still open. TE 
allows direct visualization of the tumor, the potential for 
zero-ischemia PN, and the potential for minimal damage 
to the surrounding parenchyma [5]. Furthermore, TE by 
improving preservation of normal parenchymal mass com-
pared to standard PN (SPN) has the potential to optimize 
functional recovery after PN [6]. Nevertheless, TE on a rou-
tine basis for sporadic RCC remains controversial. Some 
authors remark that 20–30% of localized RCC, even small 
renal masses, harbor potentially aggressive features and 
40–50% invade into or beyond the PC [7]. Although it was 
reported that TE is at least non-inferior to SPN for the treat-
ment of malignant cT1–T2 renal tumors in regard to positive 
surgical margins (PSM), loco-regional recurrence, and renal 
recurrence rates after a minimum follow-up of 24 months, 
the absence of PC integrity may predict the presence of posi-
tive surgical margins or have negative prognostic implica-
tions [8–11]. In this setting, preoperative imaging able to 
identify PC integrity would help to keep a safe surgical 
margin when necessary and to improve excisional precision. 
While CT is the most widely used technique for evaluation 
of renal masses, MRI has become the preferred technique to 
evaluate morphological features of RCC. In particular, tumor 
PC can be identified on MRI as a thin linear regular hypoin-
tense band surrounding the tumor on T2- and T1-weighted 
images [12]. The aim of our study was to evaluate the accu-
racy of MRI in identifying and assessing tumor PC invasion. 
Moreover, we propose a standardized classification to report 
PC status on MRI.
Materials and methods
Patients’ population
From January 2017 to June 2018, a consecutive series 
of 58 patients with organ-confined RCC (cT1 tumors) 
undergoing nephron-sparing surgery were prospectively 
enrolled in two referral centers. Inclusion criteria were: 
age ≥ 18 and evidence of renal tumor on contrast-enhanced 
CT imaging. Exclusion criteria were: contraindication to 
MRI and gross hematuria. Two patients with oncocytoma 
at final pathology were excluded from the analysis to focus 
on RCC features. All patients underwent preoperative 
abdominal MRI with a mean interval between imaging 
and surgery of ± 13.4 days (range 7–30).
MRI study protocol
MR imaging examination was performed with 3.0-T (Dis-
covery MR750; GE Medical Systems, Milwaukee, Wis). 
Turbo spin-echo T2-weighted (T2W) images (TR/TE, 
8000/120 ms; matrix, 320 × 224 section thickness, 2 mm; 
field of view, 34 cm) were obtained in axial, coronal, and 
sagittal planes. Diffusion-weighted (DW) images were 
obtained during free-breathing in the axial plane using sin-
gle-shot spin-echo echoplanar sequence with chemical shift-
selective fat-suppression techniques (b, 0–500–800–1000 s/
mm2; TR/TE, 7979/60 ms; matrix, 128 × 96; section thick-
ness, 3 mm; field of view, 34 cm). T1-weighted images were 
obtained in axial and coronal planes and were obtained post-
contrast medium injection with a fat-suppressed 3D volu-
metric spoiled gradient-echo sequence (TR/TE, 16.4/4.7 ms; 
flip angle, 15°; section thickness, 2 mm; matrix, 288 × 192) 
aimed at complete abdominal examination.
Imaging analysis
All images were independently evaluated by two experi-
enced uro-radiologists. Disagreements were resolved by 
consensus, after further examination of images. Tumor 
diameter was measured in three planes and the largest 
value was considered as the tumor size. Tumor PC was 
defined as a thin linear regular hypointense band surround-
ing the tumor on T2- and T1-weighted images. Similarly to 
the invasion of PC scoring system (i-Cap), recently devel-
oped by Snarskis et al. to standardize the histopathology 
report of tumor PC integrity, we proposed a new clas-
sification system to standardize MRI report on PC status: 
MRI-Cap [13]. MRI-Cap was evaluated on both T2-WI 
and T1WI + T2WI, and it was defined as follows:
• MRI-Cap 0: No visible hypointense rim surrounding the 
tumor on T2- and T1-weighted images (Fig. 1).
• MRI-Cap 1: Presence of a clearly identifiable, continu-
ously intact, hypointense rim surrounding the lesion on 
T2-weighted images (Fig. 2).
• MRI-Cap 2: Presence of a PC, which appears focally 
interrupted but in the absence of an obvious infiltration 
beyond its boundaries assessed on T2-weighted images. 
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No clear interruption visible on T1-weighted images 
(Fig. 3).
• MRI-Cap 3: Presence of PC which appears clearly 
interrupted and infiltrated assessed on both T2- and 
T1-weighted images (Fig. 4).
Furthermore, radiologists reported the site of possible 
PC infiltration. A 3D image reconstruction showing MRI-
Cap score was provided to both surgeon and pathologist to 
achieve complete preoperative evaluation and to compare 
imaging and pathology reports (Fig. 5).
Surgical technique and pathological assessment
All patients underwent laparoscopic partial nephrectomy, 
performed by a single experienced urologist. The resection 
technique was in all cases started as simple enucleation (SE) 
and minimal margin was preserved according to PC features 
Fig. 1  Pseudocapsule category 0: no visible hypo-intense rim visible on T1 and T2 weighted images surrounding the lesion. Papillary type I 
RCC pT1a
Fig. 2  Pseudocapsule category 1: presence of a clearly identifiable hypo-intense rim surrounding the lesion in T1 and T2 weighted images 
(pseudocapsule), which is continuously intact. Interpretation: pseudocapsule not infiltrated. ccRCC pT1a
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reported on MRI. After surgery, the specimen was properly 
marked to evaluate the concordance with the MR images.
The surgical specimens were fixed in 10% formalin solu-
tion, embedded in paraffin, and step-sectioned at 5 mm inter-
vals. Slices were then stained with hematoxylin–eosin and 
examined by a single experienced genitourinary pathologist. 
When necessary, further coupes from the paraffin slices were 
obtained.
Tumors were staged and graded according to the TNM 
classification system 7th edition, and to the Fuhrman 
grading system, respectively [14]. Histological subtypes 
were assessed according to the World Health Organization 
2004 classification [15]. Tumor PC was defined as a par-
allel band of fibrocollagenous connective tissue located at 
the interface between tumor and normal renal parenchyma. 
Mean PC thickness, PC completeness, presence and extent 
of PC invasion, as well as surgical margins status were 
reported. Pathologist used the recently introduced i-Cap 
score 1–3 to report PC invasion: i-Cap 1 was assigned to 
tumors with a completely intact PC without cancerous 
Fig. 3  Pseudocapsule category 2: presence of a pseudocapsule, which 
appears focally interrupted in the absence of an obvious infiltration 
beyond its boundaries as assessed on T2 weighted images. No clear 
interruption visible on T1 weighted images. Interpretation: pseudo-
capsule likely infiltrated. ccRCC pT1a
Fig. 4  Pseudocapsule category 3: presence of a pseudocapsule which is clearly interrupted and infiltrated as assessed on both T2 weighted and 
T1 weighted images. Interpretation: pseudocapsule definitely infiltrated. ccRCC pT1a
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invasion; i-Cap2 was assigned to tumors showing focal 
absence in PC without invasion or cancerous tissue inva-
sion partially into and yet not completely through the PC; 
i-Cap 3 was assigned to tumors that had completely lost 
PC integrity with carcinoma extending into the surrounding 
healthy parenchyma. In case of complete absence of PC, 
the pathologist referred as i-Cap 0. MRI-Cap results were 
compared with i-Cap to evaluate correlation between PC 
characteristics on images and pathology.
Statistical analysis
Preoperative MRI-Cap was compared to histology to evalu-
ate diagnostic accuracy of MRI in identifying and differenti-
ating intact from infiltrated and interrupted PC. Spearman’s 
coefficient of rank correlation (ρ) and corresponding 95% 
confidence interval was estimated for each MRI-Cap and 
i-Cap categories. Sensitivity, specificity, positive predict-
ing value (PNV), and negative predicting value (NPV) was 
calculated for each MRI-Cap category. Receiver-operating 
characteristic (ROC) curves were generated and area under 
the curve (AUC) was obtained. A p value of ≤ 0.05 was 
considered statistically significant. Statistical analysis was 
performed with SAS 9.4 version (SAS Institute Inc., Cary, 
NC, USA).
Results
Overall 58 consecutive patients (37 male and 21 female) 
with localized RCC were prospectively enrolled in the 
present study. Median age of patients was 66 years (IQR 
27–77 years). Median histologic tumor diameter was 3.2 cm 
(IQR 1.9–5.2 cm). A cancer stage of T1a was confirmed 
in 51 (88%) patients, whereas T1b was present in 7 (12%) 
patients. 7 (12%) tumors were Fuhrman grade G1, 38 (66%) 
were G2, 8 (14%) were G3, and 5 (8%) were G4. Histologic 
subtype was clear cell in 52 (90%) cases, papillary in 4 (7%), 
and chromophobe in 2 (3%). In the two patients with onco-
cytoma excluded from the analysis, PC was absent at MRI 
evaluation.
A PC was identified on preoperative MRI and con-
firmed by pathology report in 46/58 cases (79%), while it 
was absent on MRI in 12/58 (21%) cases (Table 1). A con-
cordance between MRI-Cap and i-Cap was found in 50/58 
(86%) cases, whereas 8/58 (14%) lesions were misevaluated 
Fig. 5  MRI reconstruction showing the presence of a clearly identifi-
able and continuously intact PC and renal tumor specimen: a 3D MRI 
renal mass reconstruction separated from normal kidney and surgical 
specimen. b Tumor section showing peritumoral capsule confirmed 
on pathology
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by MRI. Sensitivity, specificity, PPV, NPV, and AUC are 
reported in Table 2.
Discussion
Hricak et al. first described, in 1985, the PC on MRI, appear-
ing as a low-intensity band separating the tumor from the 
normal renal parenchyma or perirenal fat on both T1 and 
T2 sequences. T2-weighted images, however, were found 
to be the most sensitive for detecting the PC, interposed 
between the higher intensity of the tumor and normal renal 
parenchyma [16]. Lately, Roy et al. confirmed these findings 
[12]. In our series, PC was detected in 50/58 (86%) cases, 
confirming the high detection rate of MRI in this setting. The 
evaluation based on T2WI alone was consistently inferior to 
the T1WI + T2WI (difference between AUC = 0.139 ± 0.052, 
p = 0.007), and thus, we used the second analysis as radi-
ologic output. Only two false-negative (FN) cases were 
proved after pathologic evaluation with regard to the pres-
ence of PC, not detected on MR images. The two FN patients 
were pT1b G3 RCC with a less than 0.2 mm PC misevalu-
ated on MRI and identified at pathology. One MRI-Cap three 
patient was evaluated as i-Cap 2 at the final pathology.
MRI showed the best performance in identifying any 
degree of carcinoma infiltration completely through the PC 
and into the normal parenchyma (iCap3) with a sensitivity 
of 93.75%, a specificity of 95%, a PPV of 88%, an NPV of 
97%, and an AUC 0.94.
Based on our results, MRI in patients with RCC should be 
indicated preferably when CT scan is unable to detect intact 
PC surrounding the entire tumor.
In fact, as reported in the previous studies, MRI was iden-
tified as the most accurate imaging modality in the detection 
of PC, with a sensitivity of 54–93%, whereas CT is only 
10–26% [17–19].
According to emerging research, innovative and more 
recent sequences, such as Arterial Spin Labelling, in com-
bination with classical T2 sequences, could further improve 
the detection of PC invasion [20].
This finding could be of crucial clinical importance when 
considering PN approach.
It has been suggested that the PC could act as an anatomic 
guide for the surgeon in avoiding PSM [21]. Although retro-
spective series suggest similar oncologic outcomes between 
SE and PN [22], there are still concerns about the risk of 
PSM associated with this procedure. However, there is evi-
dence, suggesting that even though PSM is associated with 
a higher risk of recurrence, it does not appear to influence 
CSS [23, 24].
There is still debate on the most appropriate technique 
to perform PN and treatment decisions vary depending on 
urologist’s training and individual experience. Adapting 
PN techniques to improve preservation of functional out-
comes without undermining oncologic principles is of cru-
cial importance. For long time, NSS comprised a minimal 
layer of normal-appearing parenchyma to guarantee com-
plete tumor resection, which is a cardinal principle in the 
surgical management of neoplastic diseases [25, 26]. To 
improve functional outcomes off-clamp, minimally ischemic 
and selective clamping techniques have been described and 
simple tumor enucleation has been shown to be safe and 
effective [14]. Among NSS techniques, TE is the one that 
maximally preserves normal renal parenchyma and is ena-
bled by the presence of tumor PC [3]
Authors pro TE underline how it guarantees equivalent 
oncologic control, enhanced surgical precision, possible 
Table 1  MRI-Cap versus i-Cap score showing concordance between 
preoperative MRI and final pathology evaluation of PC
MRI-Cap i-Cap Total
0 1 2 3
0 10 2 0 0 12
1 0 10 3 0 13
2 0 0 15 2 17
3 0 0 1 15 16
10 12 19 17 58
Table 2  ρ coefficient, sensitivity, specificity, PPV, NPV and AUC of MRI PC evaluation compared to i-Cap
MRI-Cap 0 /
i-Cap 0
MRI-Cap 1/
i-Cap 1
MRI-Cap 2 /
i-Cap 2
MRI-Cap 3 /
i-Cap 3
Global
ρ coefficient 0.89
(IC95% 0.83–0.94)
0.75
(IC95% 0.60–0.84)
0.76
(IC95% 0.63–0.85)
0.87
(IC95% 0.79–0.92)
0.94
(IC95% 0.90–0.96)
Sensitivity 97.8% 77% 88% 94%
Sensibility 83.3% 95.5% 90% 95%
PPV 95.8% 83.3% 79% 88%
NPV 90.9% 93.5% 95% 97%
AUC 0.91 0.86 0.89 0.94
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fewer complications, and avoidance of warm ischemia and 
complex renorrhaphy.
Opponents claim that, although TE can preserve more 
parenchyma and offer other potential advantages, for most 
patients with sporadic RCC, the clinical benefit is marginal. 
Patients more likely to benefit of TE are those with preexist-
ing severe chronic kidney disease and solitary kidney [5].
In our experience, all PNs started always as SE to maxi-
mize healthy renal parenchyma preservation. Since a key 
step SE is the identification of the cleavage plane, all the pro-
cedures are mandatorily carried out under direct vision. As 
a consequence, the decision to include a minimum margin 
of healthy parenchyma was evaluated case by case intraop-
eratively when information about PC was not available. For 
the current study, minimal margin was preserved according 
to PC features reported on MRI.
Surgeons may apply different resection techniques along 
the contours of a tumor during PN. Taking into consideration 
that the most important factors influencing renal function are 
the preoperative renal function and the volume of healthy 
renal parenchyma that the surgeon can spare during tumor 
resection, imaging, and strategies that allow optimization of 
the modifiable factors are fundamental for PNs’ outcomes.
Therefore, in this scenario, a detailed preoperative 
identification of PC integrity could help clinical decision-
making on the most appropriate approach to PN with the 
aim of keeping a safe surgical margin when necessary and 
to improve excisional precision. An interest in evaluating 
peritumoral PC status has been developed since the 1940s, 
when early studies reported a low proportion of PC involve-
ment by cancer [15, 27]. Lately, in the 1980s, Rocca Ros-
setti described the PC of renal cell carcinoma also from the 
ultrastructural point of view and concluded that tumors up 
to 7 cm in diameter had a PC often intact and that, therefore, 
the capsular integrity was the permitting condition of the 
enucleation. In fact, in case of discontinuity of the capsule, 
the tumor infiltration of the adjacent renal parenchyma was 
systematically observed. Rosenthal et Zingg first observed 
that PC invasion was more common in less differenti-
ated renal tumors, suggesting a possible association with 
a greater risk of clinical progression [28]. More recently, 
studies reported a 14–33% of PC involvement [29, 30]. 
Minervini et al. reported the presence of a continuous, non 
fenestrated, layer of dense connective fibrous tissue com-
pletely surrounding the tumor in 100% of patients treated 
with TE in their series. They also classified PC status at the 
parenchymal side as: intact and free from invasion (PS−) or 
with signs of neoplastic infiltration within its layers, with 
or without invasion beyond it (PS+). PS- was reported in 
66.7% of RCC, whereas, in 33.3% of cases, there were signs 
of infiltration within PC layers, with or without invasion 
beyond it (PS+). PC invasion on the parenchymal side was 
observed in 26.6% of tumors, of those 11 tumors (12.2% 
overall) had PS penetration and 13 tumors (14.4% overall) 
had PS penetration and invasion beyond it. PS+ was sig-
nificantly associated with clinical and pathological tumor 
size, presence of necrosis, and pathological nuclear grade, 
whereas no statistically significant correlation was seen as 
regards tumor stage (pT1a vs pT1b) and histologic subtype 
(clear cell vs papillary vs chromophobe) [26].
Successively, the same group reported that there were no 
significant predictors of partial vs absent PC invasion. Based 
on these findings, they suggest that a binomial reporting sys-
tem of PC invasion (complete vs partial or absent) might be 
of superior clinical relevance compared to i-Cap score [31].
Volpe et al. first proposed a standardized histologic defi-
nition and classification of patterns of renal tumor PC inva-
sion (RTPI) and investigated its possible prognostic signifi-
cance. They described two main patterns of RTPI: expansive 
(presence of tumor cells that abutted the PC which, how-
ever, remained regular, well defined, and without breaks) 
and infiltrative (presence of tumor cells penetrating into the 
PC with spikes reaching varying depth). Expansive or infil-
trative RTPI were observed in 39.5% and 51.6% of cases, 
respectively. No statistically significant association was 
found between RTPI pattern and pathological size and stage, 
whereas a significant association was described for grade 
and histologic subtype (no RTPI was reported in 31.2% of 
chromophobe RCCs, 11.1% of papillary RCCs, and 6.4% of 
clear cell RCCs) [30]. At a multivariate analysis, both tumor 
histology and higher Fuhrman grade were associated with 
an increased risk of i-Cap 3 score, with papillary type and 
Fuhrman grade 4 carrying the highest risk (OR 3.04, 95% 
CI 1.52–6.09, p = 0.002; OR 14.68, 95% CI 2.16–123.18, 
p = 0.007) [13].
Indications, approaches, and techniques for PN, as well 
as correct reporting of outcomes, are still a matter of great 
debate within the urology community. The design of high-
quality multi-institutional studies evaluating long-term 
oncologic outcomes for complex renal masses based on 
standardized patient selection and surgical technique report 
is needed to better address this issue [32].
In this context, renal mass imaging allows detailed deline-
ation of the anatomy and vasculature and permits nephrom-
etry scoring, and thus precise, patient-specific surgical plan-
ning [33].
Moreover, imaging can help further research to define 
the optimal strategy for tumor excision during PN accord-
ing to the specific anatomic characteristics of each renal 
tumor. According to Minervini et al., resection technique 
might be different from resection strategy and that routine 
assessment of tumor excision descriptors using standard-
ized reporting models should be mandatory in future PN 
series to compare the outcomes of different surgical tech-
niques in a meaningful way [34, 35].
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The knowledge of the precise location of PC infiltra-
tion, in this context, could help to insert a further tile 
in the mosaic of information required to plane the most 
appropriate surgical approach. The emerging augmented 
reality techniques may also enhance information about PC 
and, perhaps, help giving a more correct indication for TE 
rather than renal resection.
Based on the evidence about PC features or PC not 
shown on MRI, urologists could evaluate the possibility 
to perform renal biopsy to assess tumor histology prior 
to surgery. The presence of PC at MRI and the absence 
at histopathological analysis were never observed in our 
study supporting MRI reliability.
We must acknowledge some limitations of our study. 
First of all, a limited number of patients were enrolled. 
Second, images were evaluated by experienced uro-radi-
ologists and specimens were evaluated by a single experi-
enced uro-pathologist. Therefore, inter-observer variations 
and institutional biases cannot be excluded. Third, i-Cap 
and MRI-Cap are quality tools proposed to standardize PC 
status, but their clinical implication needs to be defined 
and confirmed by further larger multicenter studies. Not-
withstanding all these limitations, to our knowledge, this 
is the first study that attempts to classify and grade tumor 
PC.
Conclusion
MRI is accurate in evaluating renal tumor PC. PC fea-
tures can provide an imaging-guided landmark to figure 
out where and whether a minimal margin could be desir-
able during nephron-sparing surgery.
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